Technical Analysis for NEXI - NexImmune, Inc.

Grade Last Price % Change Price Change
F 5.60 -3.28% -0.19
NEXI closed down 3.28 percent on Monday, March 18, 2024, on 5 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 26
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -3.28%
Narrow Range Bar Range Contraction -3.28%
Wide Bands Range Expansion -3.28%
Oversold Stochastic Weakness -3.28%
200 DMA Support Bullish -7.44%
Narrow Range Bar Range Contraction -7.44%

   Recent Intraday Alerts

Alert Time
Down 5% about 10 hours ago
10 DMA Resistance about 13 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Down 3% about 14 hours ago
Up 5% about 14 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

Is NEXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.6949
52 Week Low 1.2501
Average Volume 1,491,075
200-Day Moving Average 5.96
50-Day Moving Average 8.20
20-Day Moving Average 6.54
10-Day Moving Average 6.07
Average True Range 1.13
RSI (14) 37.89
ADX 40.81
+DI 34.18
-DI 17.21
Chandelier Exit (Long, 3 ATRs) 6.41
Chandelier Exit (Short, 3 ATRs) 8.89
Upper Bollinger Bands 7.98
Lower Bollinger Band 5.10
Percent B (%b) 0.17
BandWidth 43.94
MACD Line -0.63
MACD Signal Line -0.58
MACD Histogram -0.0523
Fundamentals Value
Market Cap 7.29 Million
Num Shares 1.3 Million
EPS -42.05
Price-to-Earnings (P/E) Ratio -0.13
Price-to-Sales 0.00
Price-to-Book 1.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.47
Resistance 3 (R3) 6.53 6.31 6.33
Resistance 2 (R2) 6.31 6.09 6.28 6.28
Resistance 1 (R1) 5.95 5.95 5.84 5.89 6.23
Pivot Point 5.73 5.73 5.67 5.70 5.73
Support 1 (S1) 5.37 5.51 5.26 5.31 4.97
Support 2 (S2) 5.15 5.37 5.12 4.92
Support 3 (S3) 4.79 5.15 4.88
Support 4 (S4) 4.73